DNLI vs RF
Denali Therapeutics Inc (DNLI) versus RF (RF) — a side-by-side from cached financials, not a winner call.
Denali Therapeutics Inc (DNLI) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported DNLI revenue for 2024-12-31 was $0. Net income was -$422.8M. Revenue was down 100.0% from 2023-12-31 to 2024-12-31. DNLI currently screens at market cap $2.11B.
RF does not have a complete income-statement cache yet.
DNLI currently screens at market cap $2.11B. RF currently screens at market cap $0.
Not investment advice. Open the DNLI and RF stock pages for the full models.
Not investment advice.